Skip to content
★ Sign in to follow
LB

Luca Benatti

Board Director
Director
Intercept Pharmaceuticals, Inc.IRulya Therapeutics Inc.
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
15
Companies
2
▲ Purchases (2 ops.)
€179k
▼ Sales (1 ops.)
€147k

Latest filing published 29 Dec 2025 for IRulya Therapeutics Inc., €147k.

Filing timeline

BuySale
Luca Benatti

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Luca Benatti: trading record in brief

Luca Benatti, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Intercept Pharmaceuticals, Inc. and IRulya Therapeutics Inc. In total, 15 filings cover trades dated from 15 December 2014 to 26 December 2025.

The open-market side counts 2 purchases for €179k alongside 1 sale for €147k. Purchases outweigh sales by €32k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 9 share grants. Since January 2025: no purchases and 1 sale on the market.

The newest entry dates from 29 December 2025: an open-market sale of €147k, in IRulya Therapeutics Inc. The latest purchase dates back some time: it was published 2,735 days ago, on 14 May 2019. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Luca Benatti

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations